Images courtesy: MagicLeap

Support our mission

Disability must not mean giving up our independence, our freedom to fulfill our dreams or contribute to the society. Our mission is to empower the disabled with the same level of communication and computer access as everyone else. We need your help in improving the technology and bringing it to the market. Support us and help usher in the next leap in communication, computer access and assistive technology.

  • Traditional Speech Device

    Needs different mounts for wheelchair, desk or bed-side.

    Needs accurate head position for eye tracker.

  • AR glasses

    No mounts! Just put on the glasses and it works.

    Eye tracker built into the glasses.

Holographic display

See your surroundings as well as holographic screens projected wherever you want

No Mounts!

Just wear glasses and it works! No need to worry about eye tracker position or lug around heavy mounts

Pilot Program

We are looking for the first 10 trial users to give us feedback and help improve the product. 

  • Duration
    Three months, from Aug 15, 2022 to Nov 15, 2022.

  • Cost
    $1000 to cover the cost of hardware. The product is yours at the end of the pilot.

  • What you get
    At the end of the pilot, you get:
    • A fully functioning speech device based on cutting edge Augmented Reality glasses.
    • Your feedback and specific needs incorporated into the design.
    • Honorary mention on the Abilitare website as an early supporter of the product! (Optional)

  • Refunds
    If you are unhappy with the product at the end of the pilot, return the product for a full refund. (Refunds will be processed on Nov 15.)

  • Limited seats
    Only 10 seats available, registrations end Aug 10.

  • Eligibility
    The following diagnoses are eligible to participate:
    • ALS (Amyotrophic Lateral Sclerosis)
    • Cerebral Palsy
    • Other neurodegenerative diseases
    • Parkinson's disease
    • Muscular Dystrophy
    • Spinal Cord Injury

 

Only available in the United States of America.